Showing results (151-160 of 646) with videos related to
Sort By:
Pageof 65
Seminars in Hematology|January 15, 2011
Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunitiesAlex R Minter, Haley Simpson, Brendan M Weiss, et al.Leukemia & Lymphoma|May 31, 2011
CD30: an important new target in hematologic malignanciesYehuda E Deutsch, Tamar Tadmor, Eckhard R Podack, et al.British Journal of Haematology|June 6, 2020
The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift?Dickran Kazandjian, Clifton C Mo, Ola Landgren, et al.Current Oncology Reports|April 27, 2024
Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and OpinionsMina Meseha, James Hoffman, Dickran Kazandjian, et al.Education for Health (Abingdon, England)|April 14, 2017
Emotional intelligence: A unique group training in a hematology-oncology unitTamar Tadmor, Niva Dolev, Dina Attias, et al.Harefuah|March 26, 2016
[THE PROGNOSTIC IMPACT OF CHROMOSOMAL ABERRATIONS IN TUMOR TISSUE BIOPSIES FROM PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA]Ibrahim Fahoum, Mira Ziv, Hanna Bar-El, et al.Harefuah|March 26, 2016
[EMOTIONAL INTELLIGENCE EQ--A NECESSARY SKILL FOR SUCCESS OF MEDICAL STAFF IN THE 21ST CENTURY]Tamar Tadmor, Niva Dolev, Dina Attias, et al.Haematologica|July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaOhad Benjamini, Lior Rokach, Gilad Itchaki, et al.Leukemia & Lymphoma|June 12, 2015
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the targetFortunato Morabito, Massimo Gentile, John F Seymour, et al.Cancer Journal (Sudbury, Mass.)|April 25, 2009
Current insight on trends, causes, and mechanisms of Hodgkin's lymphomaNeil E Caporaso, Lynn R Goldin, William F Anderson, et al.Pageof 65